Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH
Authors
Keywords
-
Journal
JOURNAL OF LIPID RESEARCH
Volume 56, Issue 2, Pages 277-285
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2014-12-18
DOI
10.1194/jlr.m053785
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial
- (2014) Yumie Takeshita et al. DIABETOLOGIA
- 2013 ACC/AHA Guideline Recommends Fixed-Dose Strategies Instead of Targeted Goals to Lower Blood Cholesterol
- (2014) Sidney C. Smith et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome
- (2013) Derrick M. Van Rooyen et al. JOURNAL OF HEPATOLOGY
- Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis
- (2013) George N. Ioannou et al. JOURNAL OF LIPID RESEARCH
- Steatohepatitis in laboratory opossums exhibiting a high lipemic response to dietary cholesterol and fat
- (2012) Jeannie Chan et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- A truncating mutation of Alms1 reduces the number of hypothalamic neuronal cilia in obese mice
- (2012) Déborah Heydet et al. Developmental Neurobiology
- Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis
- (2012) Christopher Savard et al. HEPATOLOGY
- LDL Receptor Knock-Out Mice Are a Physiological Model Particularly Vulnerable to Study the Onset of Inflammation in Non-Alcoholic Fatty Liver Disease
- (2012) Veerle Bieghs et al. PLoS One
- Melanocortin 4 Receptor–Deficient Mice as a Novel Mouse Model of Nonalcoholic Steatohepatitis
- (2011) Michiko Itoh et al. AMERICAN JOURNAL OF PATHOLOGY
- Hepatic Free Cholesterol Accumulates in Obese, Diabetic Mice and Causes Nonalcoholic Steatohepatitis
- (2011) Derrick M. Van Rooyen et al. GASTROENTEROLOGY
- Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice
- (2011) Savitha Subramanian et al. JOURNAL OF LIPID RESEARCH
- Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver
- (2011) Michal Ganz WORLD JOURNAL OF GASTROENTEROLOGY
- Atorvastatin and Antioxidants for the Treatment of Nonalcoholic Fatty Liver Disease: The St Francis Heart Study Randomized Clinical Trial
- (2010) Temitope Foster et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The Inflammasomes
- (2010) Kate Schroder et al. CELL
- Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet
- (2010) D. C. Chan et al. DIABETES CARE
- NPC1L1 and cholesterol transport
- (2010) Jenna L. Betters et al. FEBS LETTERS
- Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice
- (2010) Kristiaan Wouters et al. FEBS LETTERS
- Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot study
- (2010) Masato Yoneda et al. HEPATOLOGY RESEARCH
- Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
- (2010) Hyohun Park et al. JOURNAL OF GASTROENTEROLOGY
- Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
- (2010) Vasilios G Athyros et al. LANCET
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation
- (2010) Kristiina Rajamäki et al. PLoS One
- Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the united states population
- (2009) George N. Ioannou et al. HEPATOLOGY
- A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis
- (2009) Austin Nelson et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Esterified Cholesterol Is Highly Localized to Bruch's Membrane, as Revealed by Lipid Histochemistry in Wholemounts of Human Choroid
- (2009) Martin Rudolf et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice
- (2008) Shuqin Zheng et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis
- (2008) Kristiaan Wouters et al. HEPATOLOGY
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
- (2008) Veit Hornung et al. NATURE IMMUNOLOGY
- The Nalp3 inflammasome is essential for the development of silicosis
- (2008) Suzanne L. Cassel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
- (2008) C. Dostert et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now